Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer

Completed · Phase 2

Conditions studied: Ovarian Cancer

In brief

RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide, carboplatin, and mitoxantrone, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving chemotherapy with autologous bone marrow transplant may allow the doctor to give higher doses of chemotherapy and kill more tumor cells. PURPOSE: This phase II trial is studying how well chemotherapy and autologous bone marrow transplant work in treating patients with refractory or recurrent ovarian cancer.

Key facts

Study ID

NCT00002474

Run by

Loyola University

Starts

1991-02-01

Expected to finish

2005-10-01

Last updated by the study team

2013-05-30

Who can join

Age: any, up to 64. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Cardinal Bernardin Cancer Center at Loyola University Medical Center — Maywood, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.